<DOC>
	<DOCNO>NCT01816334</DOCNO>
	<brief_summary>The purpose study determine whether anti-inflammatory drug glucocorticoid effective treatment acute sciatica</brief_summary>
	<brief_title>Safety Efficacy Nonsteroidal Antiinflammatory ( NSAI ) Drug Glucocorticoids Acute Sciatica</brief_title>
	<detailed_description />
	<mesh_term>Sciatica</mesh_term>
	<mesh_term>Glucocorticoids</mesh_term>
	<mesh_term>Methylprednisolone</mesh_term>
	<mesh_term>Methylprednisolone Hemisuccinate</mesh_term>
	<mesh_term>Prednisolone</mesh_term>
	<mesh_term>Prednisolone hemisuccinate</mesh_term>
	<mesh_term>Prednisolone phosphate</mesh_term>
	<mesh_term>Ketoprofen</mesh_term>
	<mesh_term>Anti-Inflammatory Agents , Non-Steroidal</mesh_term>
	<mesh_term>Prednisolone acetate</mesh_term>
	<mesh_term>Methylprednisolone acetate</mesh_term>
	<mesh_term>Anti-Inflammatory Agents</mesh_term>
	<criteria>sciatica &lt; 8 week resistant treatment ambulatory Acute low back pain &gt; 48 hour ; Nondeficit patient ; Initial VAS &gt; 40/100 ; Consent patient Conflict discoradicular concordance clinical compute tomography scan magnetic resonance imaging . No contraindication methylprednisolone , ketoprofen ; No registration another protocol ; Pregnant , parturient , lactate mother ; Diabetic patient ; Patient syndrome narrow lumbar vertebral canal Patient history lumbar surgery &lt; 1 year ; Patient Cauda equina syndrome major motor disability ; Crural neuralgia Patient deficit ; Suspicion sciatica secondary , ie conflictrelated discoroot : infectious neuritis , fracture spinal bone tumor ... associate treatment pathology contraindicate administration methylprednisolone , ketoprofen .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>sciatica</keyword>
	<keyword>Anti-Inflammatory Agents , Non-Steroidal</keyword>
	<keyword>Glucocorticoids</keyword>
</DOC>